G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2001
11/20/2001	US6319426 Nanocrystal core having a selected band gap energy; shell of a semiconductor material having a band gap energy greater than that of the core; outer layer molecule having at least two linking groups and at least one hydrophilic group
11/20/2001	US6319377 Nitrogen oxide sensor
11/20/2001	US6319375 Apparatus for identifying a gas
11/20/2001	US6319362 Modelling effect of flow retention agent on the amount of filler in white water and on paper ash content; high speed; papermaking
11/20/2001	US6319359 Process for quantitatively detecting constituents of a pulp/fluid mixture
11/20/2001	US6319209 Disposable test vial with sample delivery device for dispensing sample into a reagent
11/20/2001	US6318332 Method for monitoring adequate oil lubrication of an internal combustion engine and an internal combustion engine for carrying out the method
11/20/2001	US6318193 Apparatus for use in sampling aggregate
11/20/2001	US6318166 Method for determining the mechanical properties of elongated textile test material and a device for carrying out the method
11/20/2001	US6318165 Device for measuring the stickiness of a flowable medium
11/20/2001	US6318150 Apparatus for sampling gas in a combustion appliance
11/20/2001	US6318149 Method and device for determining the joule-thomson coefficient of a fluid
11/20/2001	CA2224086C Conformationally-restricted combinatorial library composition and method
11/20/2001	CA2166164C Analytical method for evaluating flavor stability of fermented alcoholic beverages using electron spin resonance
11/20/2001	CA2163015C 5' nucleases derived from thermostable dna polymerase
11/20/2001	CA2156390C Technetium-99m labeled peptides for diagnostic imaging
11/20/2001	CA2142557C Cytotoxic factor linked with multiple sclerosis and detection and quantitation thereof
11/20/2001	CA2114941C Functionnalized polymer nanoparticles, their preparation and use
11/20/2001	CA2084521C Hepatitis c virus antigen polypeptide, production method therefor, and antibody detection method
11/20/2001	CA2065022C Rubella peptides
11/19/2001	CA2348251A1 Computerized method and apparatus for analyzing readings of nucleic acid assays
11/18/2001	CA2722134A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/18/2001	CA2477192A1 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/18/2001	CA2344565A1 Potentiometric sensor for wellbore applications
11/15/2001	WO2001086307A2 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
11/15/2001	WO2001086306A2 Affinity selected signature peptides for protein identification and quantification
11/15/2001	WO2001086305A2 Identification of modulators of gpr55 activity
11/15/2001	WO2001086304A2 Diagnostic of liver fibrosis with serum marker algorithms
11/15/2001	WO2001086303A2 Rapid tests for herbicide resistance in grasses
11/15/2001	WO2001086302A1 Assay device with timer function
11/15/2001	WO2001086301A1 Polymer composition for forming surface of biosensor
11/15/2001	WO2001086300A1 Method of measurement in chromatography
11/15/2001	WO2001086299A2 Doped nanoparticles as biolabels
11/15/2001	WO2001086298A1 Method for immobilizing recognition components
11/15/2001	WO2001086297A2 Methods of identifying the activity of gene products
11/15/2001	WO2001086296A2 Highly multiplexed reporter carrier systems
11/15/2001	WO2001086295A2 Detection of antibodies to gangliosides
11/15/2001	WO2001086294A1 Method of constructing polynucleotide microarray, apparatus for the construction and polynucleotide microarray
11/15/2001	WO2001086293A2 A method for designing and screening random libraries of compounds
11/15/2001	WO2001086292A2 Ipg assay
11/15/2001	WO2001086291A1 Method for determining biological agents in living target cells
11/15/2001	WO2001086290A1 Throughflow system
11/15/2001	WO2001086288A2 Early diagnosis of bladder tumor in urine samples
11/15/2001	WO2001086287A1 Method of screening compound having antimicrobial activity on pathogenic microorganism infecting organism having acquired immune mechanism by using organism having natural immune mechanism alone, and method of evaluating the antimicrobial activity by using organism having natural immune mechanism alone
11/15/2001	WO2001086286A1 Gas sensor calibration system
11/15/2001	WO2001086285A2 Direct detection of individual molecules
11/15/2001	WO2001086284A2 Method and device for the monitoring of gases
11/15/2001	WO2001086275A2 Chemical sensor device
11/15/2001	WO2001086274A1 Sensor and sensor system for liquid conductivity, temperature and depth
11/15/2001	WO2001086272A1 Monitoring content of meat using dual-energy x-ray absorptiometry
11/15/2001	WO2001086269A1 Method and device for the determination of the number of events with respect to the density of regular structures
11/15/2001	WO2001086266A2 Pd/v2 05 device for colorimetric h2 detection
11/15/2001	WO2001086265A2 H02 doped w03, ultra-fast, high-sensitive hydrogen sensors
11/15/2001	WO2001086264A1 Dyes and methods of detection of nucleic acid in immature red blood cells
11/15/2001	WO2001086263A2 Apparatus and methods for detecting explosives and other substances
11/15/2001	WO2001086261A1 Method and device for detecting end point of curing of resin, assembly, apparatus and method for producing assembly
11/15/2001	WO2001086258A2 Pd/ni-wo3 anodic double layer colormetric gas sensor
11/15/2001	WO2001086251A1 Method and apparatus for measuring packing properties of soil masses and other similar masses
11/15/2001	WO2001086248A2 Platelet function assay and reagent therefor
11/15/2001	WO2001086002A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of psoriasis
11/15/2001	WO2001085997A1 Improvements to the fluorescent polymer-qtl approach to biosensing
11/15/2001	WO2001085995A2 Identification of neural defects associated with the nucleosom al assembly protein 1l2 gene
11/15/2001	WO2001085993A2 Method for detecting growth hormone variations in humans, the variations and their uses
11/15/2001	WO2001085992A2 Assay for cell cycle modulators
11/15/2001	WO2001085985A1 Assay for detecting, measuring and monitoring the activities and concentrations of proteins and methods of use thereof
11/15/2001	WO2001085983A2 Methods for testing compounds useful for treating diabetic complications
11/15/2001	WO2001085982A2 Mixed cell systems for the detection of viruses
11/15/2001	WO2001085981A2 Methods for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis
11/15/2001	WO2001085980A2 Enzymatic assays for screening anti-cancer agents
11/15/2001	WO2001085978A2 Method for high-throughput lead profiling
11/15/2001	WO2001085956A2 Lipid metabolism enzymes
11/15/2001	WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	WO2001085954A2 Serine-threonine kinase-3
11/15/2001	WO2001085952A2 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof
11/15/2001	WO2001085950A2 Genes of the 1-desoxy-d-xylulose biosynthesis path
11/15/2001	WO2001085947A2 Compounds and methods for the diagnosis and treatment of babesia microti infection
11/15/2001	WO2001085946A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
11/15/2001	WO2001085944A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085941A2 Myc targets
11/15/2001	WO2001085938A1 Modified es cells and es cell-specific gene
11/15/2001	WO2001085937A2 Regulator of g protein signalling (rgs8)
11/15/2001	WO2001085936A1 F-box containing protein
11/15/2001	WO2001085935A2 Endothelial differentiation gene 6-like g protein coupled receptor
11/15/2001	WO2001085934A1 New ras guanine-nucleotide-exchange factor 1 (nrg1)
11/15/2001	WO2001085921A2 Human serine-threonine kinase-4
11/15/2001	WO2001085919A1 Hiv-producing cell line and use thereof
11/15/2001	WO2001085915A2 Identifying clusters of transcription factor binding sites
11/15/2001	WO2001085914A2 System for identifying clusters in scatter plots using smoothed polygons with optimal boundaries
11/15/2001	WO2001085913A2 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa
11/15/2001	WO2001085912A2 Presenilin enhancers
11/15/2001	WO2001085910A2 Agents that modulate dna-pk activity and methods of use thereof
11/15/2001	WO2001085901A2 Microphysiometer
11/15/2001	WO2001085798A2 Human monoclonal antibodies to dendritic cells
11/15/2001	WO2001085797A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
11/15/2001	WO2001085787A2 Stable rxr expressing cell line
11/15/2001	WO2001085785A2 Ph domain-interacting protein
11/15/2001	WO2001085784A2 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085772A2 Virulence genes, proteins, and their use

1 ... 2910 2911 2912 2913 2914 2915 2916 2917 2918 2919 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 ... 3937